RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Myriad Genetics Stock

Myriad Genetics ROE 2024

Myriad Genetics ROE

-0.34

Ticker

MYGN

ISIN

US62855J1043

WKN

897518

In 2024, Myriad Genetics's return on equity (ROE) was -0.34, a 165.89% increase from the -0.13 ROE in the previous year.

Myriad Genetics Aktienanalyse

What does Myriad Genetics do?

Myriad Genetics Inc. is a biotechnology company specializing in the research of cancer and genetic analysis technologies. The company was founded in 1991 by Mark Skolnick and has since become a global leader in personalized medicine and diagnostics. It is headquartered in Salt Lake City, Utah, USA, and employs over 2,400 employees worldwide. Myriad Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Myriad Genetics's Return on Equity (ROE)

Myriad Genetics's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Myriad Genetics's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Myriad Genetics's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Myriad Genetics’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Myriad Genetics stock

What is the ROE (Return on Equity) of Myriad Genetics this year?

The ROE of Myriad Genetics this year is -0.34 undefined.

How has the Return on Equity (ROE) of Myriad Genetics developed compared to the previous year?

The ROE of Myriad Genetics has increased by 165.89% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Myriad Genetics?

A high ROE indicates that Myriad Genetics generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Myriad Genetics?

A low ROE can indicate that Myriad Genetics is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Myriad Genetics affect the company?

A change in ROE (Return on Equity) of Myriad Genetics can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Myriad Genetics?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Myriad Genetics?

Some factors that can influence Myriad Genetics's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Myriad Genetics pay?

Over the past 12 months, Myriad Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Myriad Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Myriad Genetics?

The current dividend yield of Myriad Genetics is .

When does Myriad Genetics pay dividends?

Myriad Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Myriad Genetics?

Myriad Genetics paid dividends every year for the past 0 years.

What is the dividend of Myriad Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Myriad Genetics located?

Myriad Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Myriad Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Myriad Genetics from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Myriad Genetics pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Myriad Genetics in the year 2023?

In the year 2023, Myriad Genetics distributed 0 USD as dividends.

In which currency does Myriad Genetics pay out the dividend?

The dividends of Myriad Genetics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Myriad Genetics

Our stock analysis for Myriad Genetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Myriad Genetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.